|
ABCB7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.320620E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.095190E-01 |
| Normal-vs-Stage2 |
7.003200E-01 |
| Normal-vs-Stage3 |
1.979590E-01 |
| Normal-vs-Stage4 |
4.556200E-01 |
| Stage1-vs-Stage2 |
4.682600E-01 |
| Stage1-vs-Stage3 |
9.746000E-01 |
| Stage1-vs-Stage4 |
7.179400E-01 |
| Stage2-vs-Stage3 |
5.469800E-01 |
| Stage2-vs-Stage4 |
7.814800E-01 |
| Stage3-vs-Stage4 |
7.714800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.390210E-01 |
| Normal-vs-AfricanAmerican |
6.951600E-01 |
| Normal-vs-Asian |
2.822200E-01 |
| Caucasian-vs-AfricanAmerican |
6.490200E-01 |
| Caucasian-vs-Asian |
8.970600E-01 |
| AfricanAmerican-vs-Asian |
6.323000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.142200E-01 |
| Normal-vs-Female |
1.015160E-01 |
| Male-vs-Female |
4.928200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.989780E-01 |
| Normal-vs-Age(41-60Yrs) |
1.304790E-01 |
| Normal-vs-Age(61-80Yrs) |
4.502800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.416200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.130200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.009200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.616800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.576200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.015600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.428200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.956400E-01 |
| Classical-VS-Follicular |
1.890340E-02 |
| Classical-VS-Other |
3.919000E-01 |
| Classical-VS-Normal |
6.121400E-01 |
| Tall-VS-Follicular |
4.720200E-01 |
| Tall-VS-Other |
6.801000E-01 |
| Tall-VS-Normal |
2.354600E-01 |
| Follicular-VS-Other |
9.777600E-01 |
| Follicular-VS-Normal |
1.954330E-02 |
| Other-VS-Normal |
2.302600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.082000E-02 |
| Normal-vs-N1 |
1.767830E-02 |
| N0-vs-N1 |
2.531600E-01 |
|
|
